Friday, May 17, 2024
ADVT 
International

White House makes clear U.S. not sharing vaccines

Darpan News Desk The Canadian Press, 02 Mar, 2021 12:05 AM
  • White House makes clear U.S. not sharing vaccines

The White House is making it abundantly clear it has no plans to share America's COVID-19 vaccines with Canada or Mexico.

Press secretary Jen Psaki has been indicating for weeks that the Biden administration would not allow the export of doses manufactured in the U.S. any time soon.

Today, with Mexico planning to explicitly ask for help, Psaki ruled the possibility out entirely.

She says President Joe Biden is focused first on making sure the vaccine is available to every American.

Mexican President Andres Manuel Lopez Obrador was expected to ask Biden directly for doses when the two meet virtually later today.

Prime Minister Justin Trudeau reportedly stopped short of making a similar request in his virtual meetings with Biden last week.

"No," Psaki said today when asked whether the U.S. would be willing to share its supply of vaccine doses.

"The president has made clear that he is focused on ensuring that vaccines are available to every American. That is our focus."

Psaki hinted last week that the White House position could change later this year once more Americans are vaccinated and the doses are no longer in such short supply.

Johnson and Johnson's single-dose COVID-19 vaccine began shipping out today after it received emergency authorization over the weekend from the U.S. Food and Drug Administration.

That now makes three vaccines that are available in the U.S., along with the Pfizer-BioNTech and Moderna vaccines.

Health Canada has yet to approve the Johnson and Johnson shot, but gave the green light last week to a vaccine developed by AstraZeneca and the University of Oxford.

MORE International ARTICLES

Lilly seeks emergency use of its antibody drug for COVID-19

Lilly seeks emergency use of its antibody drug for COVID-19
Eli Lilly and Company announced the partial results Wednesday in a news release; they have not yet been published or reviewed by independent scientists.

Lilly seeks emergency use of its antibody drug for COVID-19

Experts call Trump's rosy virus message misguided

Experts call Trump's rosy virus message misguided
The seven-day rolling average for new U.S. cases has climbed over the past two weeks to almost 42,000 per day. The nation also sees more than 700 COVID-19 deaths each day.

Experts call Trump's rosy virus message misguided

With Trump sick, all eyes on Wednesday's VP debate

With Trump sick, all eyes on Wednesday's VP debate
Questions persist about Donald Trump's health following his COVID-19 diagnosis, as well as the age of 77-year-old challenger Joe Biden.

With Trump sick, all eyes on Wednesday's VP debate

Magnitsky sanctions demanded in Iranian shootdown

Magnitsky sanctions demanded in Iranian shootdown
There were 176 people killed when the Iranian military shot down Ukraine International Airlines Flight PS752 on Jan. 8, shortly after it took off from Tehran.

Magnitsky sanctions demanded in Iranian shootdown

Berry scare: U.S. eyeing foreign produce imports

Berry scare: U.S. eyeing foreign produce imports
U.S. Trade Representative Robert Lighthizer served notice last week that the Trump administration fears domestic producers are being unfairly harmed by what they call a recent increase in berry imports from Canada and Mexico.

Berry scare: U.S. eyeing foreign produce imports

EU regulator starts safety review of coronavirus drug

EU regulator starts safety review of coronavirus drug
In a statement on Friday, the EU regulator said it isn’t clear whether remdesivir was causing the “acute kidney injury,” but that the issue “warrants further investigation.”

EU regulator starts safety review of coronavirus drug